Intrapleural Ropivacaine Infusion in Cardiac Surgery
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 116 participants.
Also called NCT07116343
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 116 participants
- Sponsor
- Saint Petersburg State University, Russia
- Registry
-
NCT07116343
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Russia
- Registry status
- Recruiting
Technical summary
Registry record NCT07116343. Randomized; quadruple masking; primary purpose treatment. Start 2025-10-22 (actual); primary completion 2027-09-25 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intrapleural Ropivacaine Infusion in Cardiac Surgery
- Acronym
- IRICS
- Condition
- Cardiac Surgery
- Condition
- Coronary Artery Disease
- Condition
- Valvular Diseases
- Intervention (Drug)
- Ropivacaine
- Intervention (Drug)
- 0.9 % NaCl
- Lead sponsor
- Saint Petersburg State University, Russia
- Collaborator
- Primorsky Regional Clinical Hospital No. 1
Record details
- Record id
cardio:ct-nct07116343- Content hash
24f83c0b025505a13bec7928d690d4c0ed4130f8e8a9e2196883fa0ced904386